Jody Corbelli

402 total citations
17 papers, 181 citations indexed

About

Jody Corbelli is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jody Corbelli has authored 17 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jody Corbelli's work include Colorectal and Anal Carcinomas (9 papers), Colorectal Cancer Treatments and Studies (9 papers) and Colorectal Cancer Surgical Treatments (7 papers). Jody Corbelli is often cited by papers focused on Colorectal and Anal Carcinomas (9 papers), Colorectal Cancer Treatments and Studies (9 papers) and Colorectal Cancer Surgical Treatments (7 papers). Jody Corbelli collaborates with scholars based in Italy. Jody Corbelli's co-authors include Stefano Tamberi, Giorgio Papiani, Maria Aurelia Barbera, Guido Biasco, Giovanni Brandi, Elisa Grassi, Valentina Agostini, Stefania Di Girolamo, Ingrid Garajová and Giovanni Luca Frassineti and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Jody Corbelli

16 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jody Corbelli Italy 8 118 63 47 41 38 17 181
Mustafa Karaağaç Türkiye 8 142 1.2× 55 0.9× 69 1.5× 28 0.7× 12 0.3× 51 229
Caterina Accettura Italy 7 104 0.9× 35 0.6× 40 0.9× 27 0.7× 42 1.1× 14 170
Mitsuru Yanagaki Japan 11 143 1.2× 86 1.4× 56 1.2× 10 0.2× 40 1.1× 48 261
Santhalingam Jegatheeswaran United Kingdom 6 162 1.4× 69 1.1× 58 1.2× 20 0.5× 134 3.5× 9 240
Azra Husić-Selimović Bosnia and Herzegovina 7 63 0.5× 63 1.0× 32 0.7× 25 0.6× 26 0.7× 27 208
Derek McWhirter United Kingdom 7 170 1.4× 62 1.0× 74 1.6× 60 1.5× 50 1.3× 15 263
Liv Marit Dørum Norway 7 172 1.5× 90 1.4× 40 0.9× 41 1.0× 11 0.3× 9 239
Irene Pecora Italy 9 130 1.1× 75 1.2× 99 2.1× 20 0.5× 18 0.5× 24 207
Mario Domenico Rizzato Italy 8 48 0.4× 46 0.7× 29 0.6× 31 0.8× 40 1.1× 24 120
Olçun Ümit Ünal Türkiye 10 132 1.1× 47 0.7× 98 2.1× 21 0.5× 20 0.5× 40 235

Countries citing papers authored by Jody Corbelli

Since Specialization
Citations

This map shows the geographic impact of Jody Corbelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jody Corbelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jody Corbelli more than expected).

Fields of papers citing papers by Jody Corbelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jody Corbelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jody Corbelli. The network helps show where Jody Corbelli may publish in the future.

Co-authorship network of co-authors of Jody Corbelli

This figure shows the co-authorship network connecting the top 25 collaborators of Jody Corbelli. A scholar is included among the top collaborators of Jody Corbelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jody Corbelli. Jody Corbelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Montroni, Isacco, Francesca Di Candido, Giovanni Taffurelli, et al.. (2024). Total neoadjuvant therapy followed by total mesorectal excision for rectal cancer in older patients real world data and proof of concept. Frontiers in Surgery. 11. 1448073–1448073.
2.
Zingaretti, Chiara, Giorgio Papiani, Sara Pini, et al.. (2022). A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study final results.. Journal of Clinical Oncology. 40(17_suppl). LBA3513–LBA3513. 16 indexed citations
3.
Grassi, Elisa, et al.. (2021). Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer. Frontiers in Oncology. 11. 601722–601722. 34 indexed citations
4.
Tamberi, Stefano, Elisa Grassi, Jody Corbelli, et al.. (2021). A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study first-stage.. Journal of Clinical Oncology. 39(15_suppl). 3607–3607. 7 indexed citations
5.
Tamberi, Stefano, Elisa Grassi, Maria Aurelia Barbera, et al.. (2020). A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer (PANDORA).. Journal of Clinical Oncology. 38(4_suppl). TPS259–TPS259. 1 indexed citations
7.
Barbera, Maria Aurelia, Jody Corbelli, Giorgio Papiani, et al.. (2019). A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study. Annals of Oncology. 30. v249–v249. 1 indexed citations
8.
Brandi, Giovanni, Davide Campana, Nicole Brighi, et al.. (2017). Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms. Journal of Chemotherapy. 30(1). 53–58. 10 indexed citations
9.
Capelli, Laura, Andrea Casadei‐Gardini, Emanuela Scarpi, et al.. (2016). No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Scientific Reports. 6(1). 37621–37621. 6 indexed citations
10.
Marisi, Giorgia, Luca Faloppi, Emanuela Scarpi, et al.. (2016). ENOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS Study. Digestive and Liver Disease. 48. e23–e23. 2 indexed citations
12.
Casadei‐Gardini, Andrea, Giorgia Marisi, Luca Faloppi, et al.. (2016). eNOSpolymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study. Oncotarget. 7(19). 27988–27999. 22 indexed citations
13.
Brandi, Giovanni, Jody Corbelli, Francesco De Rosa, et al.. (2012). Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. Langenbeck s Archives of Surgery. 397(7). 1069–1077. 12 indexed citations
14.
Garajová, Ingrid, Stefania Di Girolamo, Francesco De Rosa, et al.. (2011). Neoadjuvant Treatment in Rectal Cancer: Actual Status. PubMed. 2011. 1–12. 22 indexed citations
15.
Brandi, Giovanni, Stefania Di Girolamo, Francesca Rosa, et al.. (2011). Second-line chemotherapy in patients with biliary tract cancer.. Journal of Clinical Oncology. 29(15_suppl). e14590–e14590. 7 indexed citations
16.
Girolamo, Stefania Di, Elisabetta Nobili, Enrico Derenzini, et al.. (2011). Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma.. Journal of Clinical Oncology. 29(4_suppl). 299–299. 2 indexed citations
17.
Nobili, Elisabetta, Roberto Di Cicilia, Monica Di Battista, et al.. (2010). Venous Thromboembolism and Port-Related Thrombosis in Metastatic Colorectal Cancer Patients: A Monocenter Experience. Pathophysiology of Haemostasis and Thrombosis. 37(1). 30–34. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026